Phase 2Completed
Evaluate the Efficacy and Safety of NT-0796 in Participants With Obesity With or Without Type 2 Diabetes Mellitus (RESOLVE-1)
A Phase 2a Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of NT-0796 as an Adjunct to a Reduced Calorie Diet and Increased Physical Activity in Obese Participants With/Without Type 2 Diabetes
- Sponsor
- Rezera (formerly NodThera Limited) (Industry)
- Enrolment
- 176 enrolled
- Conditions
- Obesity and Type 2 Diabetes
- Interventions
- NT-0796; Placebo
- Ages
- adults, older adults
- Registry
- NCT07055516
Full record on ClinicalTrials.gov
From the registry
A Phase 2a Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of NT-0796 as an Adjunct to a Reduced Calorie Diet and Increased Physical Activity in Obese Participants With/Without Type 2 Diabetes over a 6 months treatment period.
Primary outcomes
- Ratio Change in hsCRP in participants with obesity and without T2DM hsCRP
- Change in body weight in participants with obesity with and without T2DM
History
Last registry update
Primary completion
Registered
Started